FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2405496543> ?p ?o ?g. }

• W2405496543 endingPage "ii" @default.
• W2405496543 startingPage "i" @default.
• W2405496543 abstract "In biology, cell death is a natural process, wherein the worn-out cells with declining function, are eventually removed from the organism. The three well-known mechanisms of cell demise are apoptosis, autophagy, and necrosis. The latest addition to this list is, still another pathway, recognized as “necroptosis.”1 In contrast to the traditional believe, that apoptosis is the only regulated or programmed cellular mechanism of cell death, established evidence suggest that necrosis can also be driven by means of a controlled succession of molecular events.2 Such controlled necrosis is termed as “programmed necrosis” or “necroptosis.”3Now the query arises, how necroptosis is different from necrosis, or are all necrosis regulated? With the present evidence and data, it is essential to comprehend that regulated or controlled necrosis is a broad term that includes mitochondrial permeability transition, necroptosis, ferroptosis, pyroptosis, Poly(ADP-ribose) polymerase 1-mediated regulated necrosis, nicotinamide adenine dinucleotide phosphate-oxidase-mediated regulated necrosis, etc. However, the uniqueness of each of these pathways are yet to be validated and defined.4The death receptors, which are member of tumor necrosis factor receptor superfamily, are the foremost mediators of cell death pathway. Consequently, when the death receptor is activated in a cell, the possible outcomes are described as follows. The first, if the nuclear factor – kappa B survival or mitogen-activated protein kinase pathway are initiated, the cell survives. The second, if the caspase-8 is activated in the absence of the survival pathways, apoptosis follows. Finally, under certain conditions where the caspases pathway is not triggered, the cell undergoes necroptosis.5 This pathway involves various molecules, of which the receptor-interacting protein kinase 1 (RIP1) and RIP3 play critical role in the initiation of necrosome formation and signaling. The hypothesis is divided from here onward, i.e., whether necroptosis is mitochondria-dependent or independent. A few research suggests role of mitochondria and reactive oxygen species (ROS) dependent necroptosis while others indicate contradictory results.1 Nevertheless, concerning the perspective of clinical application, induction of necroptosis receptors in cancer cells can be a prodigious targeted therapy.Necroptosis is relatively a new concept and hence limited studies have been piloted investigating its role in cancer progression. One of such study showed reduced lung metastasis in a case of osteosarcoma, by induction of necroptosis via RIP1 and RIP3 receptors. The triggering of ROS bursts by means of the above pathway can potentially hamper the survival of cancer cells at distant sites, away from the primary location. Further, findings show that RIP3 activates various metabolic enzymes which regulate ROS production. In another study, it was found that the chronic lymphocytic leukemia cells exhibited failure to undergo necroptosis due to the downregulation of RIP3. Likewise, RIP3 gene variation were identified in non-Hodgkin lymphoma patients.3 Apart from cancer cells, necroptosis has also been proposed to occur in immune and neuronal systems.2 Though not evidenced yet, it is postulated to mediate gastrointestinal and skin disorders like atopic dermatitis and inflammatory bowel diseases.4At the present time, there is dearth of information regarding necroptosis and cancer spread. This novel concept arises many queries yet to be answered, such as the mechanism of action involving the mitochondrion; triggering factors of necroptosis pathway; how does the tumor cells bypass necroptosis and escape cell death; its role in regulating cancer metastasis; to mention a few." @default.
• W2405496543 created "2016-06-24" @default.
• W2405496543 creator A5015496689 @default.
• W2405496543 creator A5039599940 @default.
• W2405496543 creator A5062154456 @default.
• W2405496543 date "2015-01-01" @default.
• W2405496543 modified "2023-09-23" @default.
• W2405496543 title "Necroptosis: Changing Trends in Cell Biology and Cancer." @default.
• W2405496543 cites W1974941717 @default.
• W2405496543 cites W2010766264 @default.
• W2405496543 cites W2031232016 @default.
• W2405496543 cites W2166616170 @default.
• W2405496543 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4672845" @default.
• W2405496543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26668497" @default.
• W2405496543 hasPublicationYear "2015" @default.
• W2405496543 type Work @default.
• W2405496543 sameAs 2405496543 @default.
• W2405496543 citedByCount "0" @default.
• W2405496543 crossrefType "journal-article" @default.
• W2405496543 hasAuthorship W2405496543A5015496689 @default.
• W2405496543 hasAuthorship W2405496543A5039599940 @default.
• W2405496543 hasAuthorship W2405496543A5062154456 @default.
• W2405496543 hasConcept C13591479 @default.
• W2405496543 hasConcept C17172800 @default.
• W2405496543 hasConcept C17991360 @default.
• W2405496543 hasConcept C190283241 @default.
• W2405496543 hasConcept C203014093 @default.
• W2405496543 hasConcept C2776055636 @default.
• W2405496543 hasConcept C2776550021 @default.
• W2405496543 hasConcept C31573885 @default.
• W2405496543 hasConcept C502942594 @default.
• W2405496543 hasConcept C503630168 @default.
• W2405496543 hasConcept C54355233 @default.
• W2405496543 hasConcept C55493867 @default.
• W2405496543 hasConcept C62478195 @default.
• W2405496543 hasConcept C86803240 @default.
• W2405496543 hasConcept C94030615 @default.
• W2405496543 hasConcept C95444343 @default.
• W2405496543 hasConcept C98424977 @default.
• W2405496543 hasConceptScore W2405496543C13591479 @default.
• W2405496543 hasConceptScore W2405496543C17172800 @default.
• W2405496543 hasConceptScore W2405496543C17991360 @default.
• W2405496543 hasConceptScore W2405496543C190283241 @default.
• W2405496543 hasConceptScore W2405496543C203014093 @default.
• W2405496543 hasConceptScore W2405496543C2776055636 @default.
• W2405496543 hasConceptScore W2405496543C2776550021 @default.
• W2405496543 hasConceptScore W2405496543C31573885 @default.
• W2405496543 hasConceptScore W2405496543C502942594 @default.
• W2405496543 hasConceptScore W2405496543C503630168 @default.
• W2405496543 hasConceptScore W2405496543C54355233 @default.
• W2405496543 hasConceptScore W2405496543C55493867 @default.
• W2405496543 hasConceptScore W2405496543C62478195 @default.
• W2405496543 hasConceptScore W2405496543C86803240 @default.
• W2405496543 hasConceptScore W2405496543C94030615 @default.
• W2405496543 hasConceptScore W2405496543C95444343 @default.
• W2405496543 hasConceptScore W2405496543C98424977 @default.
• W2405496543 hasIssue "Suppl 2" @default.
• W2405496543 hasLocation W24054965431 @default.
• W2405496543 hasOpenAccess W2405496543 @default.
• W2405496543 hasPrimaryLocation W24054965431 @default.
• W2405496543 hasRelatedWork W1966977448 @default.
• W2405496543 hasRelatedWork W2087666519 @default.
• W2405496543 hasRelatedWork W2275298454 @default.
• W2405496543 hasRelatedWork W2361123982 @default.
• W2405496543 hasRelatedWork W2619368432 @default.
• W2405496543 hasRelatedWork W2965501907 @default.
• W2405496543 hasRelatedWork W3004584638 @default.
• W2405496543 hasRelatedWork W3019404863 @default.
• W2405496543 hasRelatedWork W3143577155 @default.
• W2405496543 hasRelatedWork W4291000731 @default.
• W2405496543 hasVolume "7" @default.
• W2405496543 isParatext "false" @default.
• W2405496543 isRetracted "false" @default.
• W2405496543 magId "2405496543" @default.
• W2405496543 workType "article" @default.